|
ZNF619 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.4106999970478E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.32610000547606E-08 |
| Normal-vs-Stage2 |
6.643400E-03 |
| Normal-vs-Stage3 |
2.982000E-03 |
| Normal-vs-Stage4 |
5.1813000001566E-07 |
| Stage1-vs-Stage2 |
6.295400E-01 |
| Stage1-vs-Stage3 |
9.355800E-01 |
| Stage1-vs-Stage4 |
8.496300E-02 |
| Stage2-vs-Stage3 |
7.799400E-01 |
| Stage2-vs-Stage4 |
8.247800E-02 |
| Stage3-vs-Stage4 |
1.944430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.48269999903306E-08 |
| Normal-vs-AfricanAmerican |
1.54587999999789E-05 |
| Normal-vs-Asian |
1.008150E-04 |
| Caucasian-vs-AfricanAmerican |
8.699400E-01 |
| Caucasian-vs-Asian |
3.799200E-01 |
| AfricanAmerican-vs-Asian |
3.145200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05859995716651E-09 |
| Normal-vs-Female |
3.601500E-02 |
| Male-vs-Female |
7.575600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.6549999999973E-05 |
| Normal-vs-Extreme_Weight |
7.17439996300584E-10 |
| Normal-vs-Obese |
2.803200E-04 |
| Normal-vs-Extreme_Obese |
1.407830E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.710400E-01 |
| Normal_Weight-vs-Obese |
3.686200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.414000E-01 |
| Extreme_Weight-vs-Obese |
1.696400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.060000E-01 |
| Obese-vs-Extreme_Obese |
2.813600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.117500E-03 |
| Normal-vs-Age(41-60Yrs) |
5.88510000000264E-05 |
| Normal-vs-Age(61-80Yrs) |
7.17119996718196E-09 |
| Normal-vs-Age(81-100Yrs) |
3.12540000002581E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.340000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.850000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.711820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.385700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.606400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.804000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.24169999837775E-08 |
| Normal-VS-Type2 PRCC |
3.75969999577563E-08 |
| Normal-VS-KIRP CIMP |
1.911610E-01 |
| Normal-VS-Unclassified PRCC |
3.310000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.141600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.953780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.463900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.464990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.478460E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.750000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.75759464946668E-11 |
| Normal-vs-N1 |
9.839500E-03 |
| Normal-vs-N2 |
1.678030E-03 |
| N0-vs-N1 |
2.124000E-01 |
| N0-vs-N2 |
7.565200E-01 |
| N1-vs-N2 |
4.890400E-01 |
|
|
